London, United Kingdom

Marc Goldfinger

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Paige.ai, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marc Goldfinger: Innovator in Medical Imaging Technology

Introduction

Marc Goldfinger is a notable inventor based in London, GB. He has made significant contributions to the field of medical imaging technology. His work focuses on systems and methods that enhance the processing of electronic medical images to predict biomarker levels.

Latest Patents

Goldfinger holds a patent for "Systems and methods for processing images to determine biomarker levels." This innovative patent describes methods for processing digital medical images associated with pathology specimens. The technology involves a machine learning system that predicts biomarker expression levels based on transcriptomic and protein expression scores. Additionally, it generates a slide overlay to indicate regions of tissue that are most likely to contribute to the biomarker expression prediction.

Career Highlights

Goldfinger's career is marked by his dedication to advancing medical imaging technologies. His work has the potential to significantly impact the diagnosis and treatment of various medical conditions. He is currently associated with Paige.ai, Inc., a company that specializes in artificial intelligence for pathology.

Collaborations

Goldfinger collaborates with various professionals in the field, including his coworker Jillian Sue. Their combined expertise contributes to the development of innovative solutions in medical imaging.

Conclusion

Marc Goldfinger's contributions to medical imaging technology exemplify the intersection of innovation and healthcare. His patent and ongoing work at Paige.ai, Inc. highlight the importance of advancements in this critical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…